BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

11083	Companies
243263	Keywords
171446	Articles
131008	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

PRESS RELEASE

published on 07/26/2025 at 00:00, 1 year 1 month ago

BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement
BioNxt Solutions Inc. closes first tranche of non-brokered private placement, raising $1,009,200 for drug delivery tech and IP development. Securities subject to statutory hold until Nov 26, 2025

Private Placement Convertible Debentures BioNxt Solutions Inc. Intellectual Property Drug Delivery Technologies
BRIEF

published on 07/23/2025 at 09:10, 1 year 2 months ago

BioNxt Advances Cladribine Thin-Film Development

Multiple Sclerosis Cladribine Drug Delivery BioNxt Solutions Sublingual Thin-Film
BRIEF

published on 07/23/2025 at 09:10, 1 year 2 months ago

BioNxt fait progresser le développement de couches minces de cladribine

Sclérose En Plaques Cladribine Solutions BioNxt Administration De Médicaments Film Mince Sublingual
PRESS RELEASE

published on 07/23/2025 at 09:05, 1 year 2 months ago

BioNxt Delivers Positive Results in Patented Cladribine Sublingual Thin-Film Program and Completes Successful Formulation
BioNxt Solutions Inc. announces successful development of sublingual thin-film prototype for cladribine-based drug delivery in multiple sclerosis treatment, strengthening clinical development path

BioNxt Solutions Inc. Cladribine Drug Delivery Multiple Sclerosis Treatment Thin-film Prototype
BRIEF

published on 07/12/2025 at 00:05, 1 year 2 months ago

BioNxt Solutions Proposes Convertible Debenture Unit Offering

Private Placement Convertible Debenture Investor Information Product Development BioNxt Solutions
BRIEF

published on 07/12/2025 at 00:05, 1 year 2 months ago

BioNxt Solutions propose une offre d'unités d'obligations convertibles

Placement Privé Développement De Produits Informations Pour Les Investisseurs Obligation Convertible Solutions BioNxt
PRESS RELEASE

published on 07/12/2025 at 00:00, 1 year 2 months ago

BioNxt Solutions Announces Convertible Debenture Unit Private Placement
BioNxt Solutions Inc. announces $1.2M non-brokered private placement of convertible debenture units for product development and commercialization

Private Placement Convertible Debentures BioNxt Solutions Inc. Commercialization Product Development
BRIEF

published on 07/09/2025 at 03:32, 1 year 2 months ago

BioNxt Solutions Innovates Targeted Chemotherapy Drug Delivery

Precision Oncology Drug Delivery BioNxt Solutions Pharmaceutical Innovations Targeted Chemotherapy
BRIEF

published on 07/09/2025 at 03:32, 1 year 2 months ago

BioNxt Solutions innove dans l'administration ciblée de médicaments de chimiothérapie

Oncologie De Précision Solutions BioNxt Administration De Médicaments Innovations Pharmaceutiques Chimiothérapie Ciblée
PRESS RELEASE

published on 07/09/2025 at 03:27, 1 year 2 months ago

BioNxt Solutions Introduces Targeted Chemotherapy Drug Delivery Platform for Precision Oncology
BioNxt Solutions Inc. announces breakthrough targeted chemotherapy delivery platform for precision oncology, focusing on tumor-specific drug release and neutralization mechanism

Precision Oncology BioNxt Solutions Inc. Drug Delivery Targeted Chemotherapy Chemotherapy Market

Accesswire

Published on 09/25/2026 at 22:15, 13 minutes ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 4 hours 58 minutes ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 7 hours 28 minutes ago

HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/25/2026 at 14:00, 8 hours 28 minutes ago

Karbon-X (OTCQB:KARX) to Present Global Growth Strategy and Showcase SkyXero at 26th MK-Equity Investment Conference in Munich
Published on 09/25/2026 at 13:00, 9 hours 28 minutes ago

Core Silver Announces Grant of Stock Options

View all ACCESSWIRE

EQS Group

Published on 09/25/2026 at 18:30, 3 hours 58 minutes ago

029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:15, 4 hours 13 minutes ago

Warren Wise decodes Qiagen’s DNA
Published on 09/25/2026 at 18:00, 4 hours 28 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:30, 4 hours 58 minutes ago

GEVELOT S.A.: Weekly declaration of share buybacks – 09/25/2026 (French only)
Published on 09/25/2026 at 17:30, 4 hours 58 minutes ago

GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 25/09/2026

Les Echos

Published on 09/25/2026 at 18:00, 4 hours 28 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 4 hours 28 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 4 hours 43 minutes ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 4 hours 48 minutes ago

Availability of the 2026 half-year financial report
Published on 09/25/2026 at 17:40, 4 hours 48 minutes ago

Mise à disposition du rapport financier semestriel 2026

View all LES ECHOS COMFI WIRE